Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ImExHS Limited ( (AU:IME) ) has provided an announcement.
ImExHS Limited announced a change in the director’s interest, with Douglas Lingard acquiring 26,683 ordinary shares. This acquisition was made in lieu of non-executive director fees for the quarter ending 31 March 2025, reflecting a strategic move to align director interests with company performance.
More about ImExHS Limited
ImExHS Limited operates in the healthcare technology industry, focusing on providing innovative medical imaging solutions. The company offers a range of products and services aimed at enhancing diagnostic capabilities and improving patient outcomes.
YTD Price Performance: 3.95%
Average Trading Volume: 33,851
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$18.36M
See more data about IME stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “…Overlook a Lack of Earnings Power”: UBS Analysts Target Intel Stock (NASDAQ:INTC), Stock Gains
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test
- “Direct Result of Your Feedback….” Microsoft Stock (NASDAQ:MSFT) Slips as The Option to Skip Updates Emerges